Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-21-009385

Director disposed of 338,165 shares (other)

  • Director acquired 73,281 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2021-03-01 Other disposition −244,056 581,999 I
Bolzon Bradley J PhD Director 2021-03-01 Other acquisition +52,716 52,716 I
Bolzon Bradley J PhD Director 2021-03-01 Other disposition −7,341 16,625 I
Bolzon Bradley J PhD Director 2021-03-01 Other acquisition +1,585 54,301 I
Bolzon Bradley J PhD Director 2021-03-01 Other disposition −8,126 18,457 I
Bolzon Bradley J PhD Director 2021-03-01 Other acquisition +1,755 56,056 I
Bolzon Bradley J PhD Director 2021-03-01 Other disposition −56,056 0 I
Bolzon Bradley J PhD Director 2021-03-01 Other acquisition +12,648 60,184 D
Bolzon Bradley J PhD Director 2021-03-01 Other disposition −18,574 44,295 I
Bolzon Bradley J PhD Director 2021-03-01 Other acquisition +4,012 4,012 I
Bolzon Bradley J PhD Director 2021-03-01 Other disposition −4,012 0 I
Bolzon Bradley J PhD Director 2021-03-01 Other acquisition +565 60,749 D
Loading xslF345X03/doc4.xml…